Aniridia: genes and variants
Explore variant evidence for Aniridia across 1 analyzed protein (PAX6). Linked ClinVar records include 60 pathogenic or likely pathogenic variants, 88 variants of uncertain significance and 9 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Aniridia
PAX6: Paired box protein Pax-6
It orchestrates developmental gene programs in the eye, forebrain, and pancreatic endocrine system. Haploinsufficiency most classically causes aniridia and can also produce broader ocular, endocrine, and neurodevelopmental abnormalities.
60 ClinVar pathogenic / likely pathogenic and 96 uncertain variants in PAX6 have source records linked to Aniridia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SOX2.
Where Aniridia variants cluster
- PAX6 PAI subdomain (positions 7–63): 22 of 25 ClinVar pathogenic / likely pathogenic variants, 6.5× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Aniridia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PAX6 G18R | 18 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 R26W | 26 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 R38Q | 38 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 R38G | 38 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 R38W | 38 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 V78E | 78 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 R128C | 128 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 G13R | 13 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 G12R | 12 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 S43F | 43 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 G51R | 51 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 G72C | 72 | Paired | Pathogenic / likely pathogenic (★★) |
| PAX6 Q255H | 255 | Homeobox | Pathogenic / likely pathogenic (★★) |
| PAX6 G18W | 18 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 R26Q | 26 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 G36E | 36 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 R38P | 38 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 Q47L | 47 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 V53L | 53 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 P76L | 76 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 P76Q | 76 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 V78L | 78 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 R128P | 128 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 R214S | 214 | Homeobox | Pathogenic / likely pathogenic (★) |
| PAX6 G72S | 72 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 A37P | 37 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 C52W | 52 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 R125G | 125 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 Q211R | 211 | Homeobox | Pathogenic / likely pathogenic (★) |
| PAX6 M1I | 1 | Pathogenic / likely pathogenic (★) | |
| PAX6 M1L | 1 | Pathogenic / likely pathogenic (★) | |
| PAX6 A99T | 99 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 L106S | 106 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 S119R | 119 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 I123K | 123 | Paired | Pathogenic / likely pathogenic (★) |
| PAX6 G194R | 194 | Pathogenic / likely pathogenic (★) | |
| PAX6 R208Q | 208 | Pathogenic / likely pathogenic (★) | |
| PAX6 R261Q | 261 | Homeobox | Pathogenic / likely pathogenic (★) |
| PAX6 G395R | 395 | Required for suppression of NFATC1-mediated tran | Pathogenic / likely pathogenic (★) |
| PAX6 G409R | 409 | Required for suppression of NFATC1-mediated tran | Pathogenic / likely pathogenic (★) |
| PAX6 S155G | 155 | Pathogenic / likely pathogenic (★) | |
| PAX6 G18A | 18 | Paired | Pathogenic / likely pathogenic |
| PAX6 R26G | 26 | Paired | Pathogenic / likely pathogenic |
| PAX6 G36V | 36 | Paired | Pathogenic / likely pathogenic |
| PAX6 Q47P | 47 | Paired | Pathogenic / likely pathogenic |
| PAX6 Q47R | 47 | Paired | Pathogenic / likely pathogenic |
| PAX6 V53G | 53 | Paired | Pathogenic / likely pathogenic |
| PAX6 R128H | 128 | Paired | Pathogenic / likely pathogenic |
| PAX6 R214G | 214 | Homeobox | Pathogenic / likely pathogenic |
| PAX6 G7R | 7 | Paired | Pathogenic / likely pathogenic |
| PAX6 N17K | 17 | Paired | Pathogenic / likely pathogenic |
| PAX6 L32V | 32 | Paired | Pathogenic / likely pathogenic |
| PAX6 I42S | 42 | Paired | Pathogenic / likely pathogenic |
| PAX6 K55T | 55 | Paired | Pathogenic / likely pathogenic |
| PAX6 L57P | 57 | Paired | Pathogenic / likely pathogenic |
| PAX6 G64V | 64 | Paired | Pathogenic / likely pathogenic |
| PAX6 R92P | 92 | Paired | Pathogenic / likely pathogenic |
| PAX6 I102N | 102 | Paired | Pathogenic / likely pathogenic |
| PAX6 R242T | 242 | Homeobox | Pathogenic / likely pathogenic |
| PAX6 R147G | 147 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Aniridia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| PAX6 G7V | 7 | Paired | Uncertain (★) | +7: in a 3D region that tolerates change poorly (1E); G7R at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.879 |
| PAX6 G72R | 72 | Paired | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G72C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| PAX6 Q47H | 47 | Paired | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; Q47P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| PAX6 G72A | 72 | Paired | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; G72C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| PAX6 R125T | 125 | Paired | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; R125G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| PAX6 I42L | 42 | Paired | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; I42S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| PAX6 G13D | 13 | Paired | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; G13R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| PAX6 G51E | 51 | Paired | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; G51R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| PAX6 L32R | 32 | Paired | Uncertain (★) | +6: in a 3D region that tolerates change poorly (1E); L32V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| PAX6 R125S | 125 | Paired | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; R125G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
Which prediction tools work for Aniridia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 96 out of 100
- MetaLR: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 95 out of 100
- PolyPhen-2: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 80 out of 100
Same protein, different disease
- Coloboma, ocular, autosomal dominant also has ClinVar records linked to PAX6 variants; they fall in the same places as the Aniridia variants (5 pathogenic / likely pathogenic).
Diseases related to Aniridia
- Irido-corneo-trabecular dysgenesis, also linked to PAX6
- Autosomal dominant optic atrophy classic form, also linked to PAX6
- Coloboma, ocular, autosomal dominant, also linked to PAX6
- Foveal hypoplasia 1, also linked to PAX6
Frequently asked questions
Which genes have records linked to Aniridia?
This view contains 1 analyzed proteins: PAX6. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 60 pathogenic or likely pathogenic variants, 88 variants of uncertain significance and 9 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 10 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 162 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center